Search
S-(Methylmercury)-L-Cysteine
go.drugbank.com/drugs/DB02750ExperimentalSynonyms: S-(Methylmercury)-L-CysteineS-(3-Iodobenzyl)glutathione
go.drugbank.com/drugs/DB04341ExperimentalSynonyms: S-(3-Iodobenzyl)glutathioneS-(4-BROMOBENZYL)CYSTEINE
go.drugbank.com/drugs/DB08370ExperimentalSynonyms: S-(4-BROMOBENZYL)CYSTEINE(S)-2-Tetrahydrofuroic acid
go.drugbank.com/drugs/DB03051ExperimentalSynonyms: (S)-2-Tetrahydrofuroic acid, (S)-(-)-2-Tetrahydrofuroic acidAstraZeneca COVID-19 Vaccine
go.drugbank.com/drugs/DB15656ApprovedInvestigationaladenovirus capable of producing the spike (S) protein of SARS-CoV-2, allowing for the formation of endogenous antibodies against these proteins and, consequently, against SARS-CoV-2. … The AstraZeneca COVID-19 Vaccine (previously known as ChAdOx1 nCoV-19 or AZD1222) is one of several vaccines developed in 2020 for the prevention of COVID-19 caused by SARS-CoV-2.
Synonyms: ChAdOx-1-S[recombinant], ChAdOx1-S [recombinant]Levobunolol
go.drugbank.com/drugs/DB01210ApprovedA nonselective beta-adrenoceptor antagonist used in the treatment of glaucoma.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2D6 SubstratesSynonyms: (S)-5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenoneMetamfetamine
go.drugbank.com/drugs/DB01577ApprovedIllicitInvestigationalWithdrawnMetamfetamine (methamphetamine) is a psychostimulant and sympathomimetic drug, and a member of the amphetamine group of sympathomimetic amines. … It is a scheduled drug in most countries due to its high potential for addiction and abuse.
Categories: Cytochrome P-450 Substrates, Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substratesSynonyms: (+)-(S)-N-α-dimethylphenethylamine, (S)-N,α-dimethylbenzeneethanamineDuloxetine
go.drugbank.com/drugs/DB00476ApprovedInvestigationalDuloxetine is a dual serotonin and norepinephrine reuptake inhibitor.[label] It was originally discovered in 1993 and developed by Eli Lilly and Company as LY248686. … [A178741] Duloxetine first received approval from the FDA in August, 2004 as Cymbalta for the treatment of Major Depressive Disorder.
Categories: P-glycoprotein inhibitors, Cytochrome P-450 SubstratesSynonyms: (S)-duloxetine, (3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amineAlmitrine
go.drugbank.com/drugs/DB01430ApprovedAlmitrine is a respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. … It is also reported to have a potentially beneficial effect in treating the noctural oxygen desaturation without impairing the quality of sleep.
Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-RingSynonyms: 2,4-Bis(allylamino)-6-(4-(bis(p-fluorophenyl)methyl)-1-piperazinyl)-s-triazine